CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 350 enrolled
Drug / intervention
Standard PVI Ablation +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02274857
NCT02274857N/ACompleted

Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided Procedures (REAFFIRM)

Abbott Medical Devices·interventional·Posted Oct 24, 2014·Updated Feb 7, 2020

In Brief

A clinical study evaluating Standard PVI Ablation and FIRM-Guided Procedure and PVI for Persistent Atrial Fibrillation. Completed, enrolled 350 participants across 18 sites in 3 countries.

Detailed Summary

The study is a prospective, multicenter, randomized study to assess the safety and effectiveness of FIRM procedures followed by conventional ablation including PVI versus a standard PVI procedure for the treatment of persistent atrial fibrillation (AF).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesGermany, Netherlands, United States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 24, 2014
Enrollment StartOct 1, 2014
Primary CompletionNov 10, 2018
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 11.7 years ago

Interventions

Standard PVI Ablationprocedure

Standard PVI procedure without FIRMap.

FIRM-Guided Procedure and PVIprocedure

FIRM-guided procedure followed by conventional ablation including PVI.